• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT HBSAG QUALITATIVE II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT HBSAG QUALITATIVE II Back to Search Results
Catalog Number 02G22-30
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/23/2019
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product list 2g22, that has a similar us product distributed in the us, list 4p53.Patient identifier, does not contain enough spaces, full id is (b)(6).An evaluation is in process.A followup report will be submitted when the evaluation is complete.
 
Event Description
The account generated (b)(6) on a donor ((b)(6) year old non-caucasian male) id (b)(6) on (b)(6) 2019.Additionally, the donor tested (b)(6), murex (b)(6), biorad (b)(6).No impact to patient/donor was reported.No additional specific patient information provided.
 
Manufacturer Narrative
Complaint ticket searches identified normal complaint activity for lot 94053fn00.Complaint trending report review determined no adverse trend for the issue for the product.The 2 return patient sample tubes were tested using an in-house retained kit of lot 94053fn00 and the hbsag q ii results (0.83 and 0.72 s/co) matched the nature of the customer complaint (nonreactive result).Clinical sensitivity testing was performed using an in-house retained kit of lot 94053fn00.All specifications were met indicating the lot is preforming acceptably.A review of the product quality history for lot 94053fn00 using search of the corrective and preventive actions system did not identify any issues associated with the customer observation.A review of product labeling concluded that the issue is sufficiently addressed.Using worldwide data a review of customer field data was performed for the assay which showed no atypical performance for the lot.No product deficiency was identified.
 
Manufacturer Narrative
Update to section lot number and section an evaluation is in process.A followup report will be submitted when the evaluation is complete.
 
Event Description
Additional information provided that the account stated the hepatitis b positive donor obtained a new sample which generated pcr positive results but architect method negative (0.97 s/co) and reactive (1.05 s/co) results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG QUALITATIVE II
Type of Device
HBSAG
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8764660
MDR Text Key194157426
Report Number3008344661-2019-00080
Device Sequence Number1
Product Code KSJ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 09/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/05/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/12/2019
Device Catalogue Number02G22-30
Device Lot Number94053FN00
Was Device Available for Evaluation? No
Date Manufacturer Received08/28/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT LIST 03M74-02; ARCHITECT LIST 03M74-02; ARCHITECT LIST 03M74-02; SERIAL (B)(4); SERIAL (B)(4); SERIAL (B)(4)
Patient Age38 YR
-
-